HighLife wins FDA breakthrough nod for TMVR tech
April 8, 2025
HighLife announced that it received FDA breakthrough device designation for its trans-septal mitral valve replacement (TMVR) solution.
HighLife announced that it received FDA breakthrough device designation for its trans-septal mitral valve replacement (TMVR) solution.
Brainomix announced today that it received FDA clearance for a new feature within its 360 Stroke solution for AI-powered stroke imaging.
Proprio announced today that it received its second FDA 510(k) clearance for its Paradigm AI guidance platform for surgery.
CardioVia announced today that it received FDA clearance for its minimally invasive ViaOne epicardial access system.
Advanced Dosimetry Software Expands Capabilities for Personalized Radiopharmaceutical Therapies
Breakthrough Innovation Promises Superior Sensitivity and Precision in Radiation Detection Technologies